Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Small Plaque Psoriasis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01585233
What this trial is testing

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Astellas Pharma Global Development, Inc. 60
Early research (Phase 1)Study completedNCT02548052
What this trial is testing

Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis

Who this might be right for
Psoriasis
GlaxoSmithKline 15
Testing effectiveness (Phase 2)Study completedNCT03010527
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 217
Testing effectiveness (Phase 2)Active Not RecruitingNCT07290569
What this trial is testing

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 160
Large-scale testing (Phase 3)Study completedNCT05637515
What this trial is testing

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque Psoriasis
Biocon Biologics Inc. 374
Not applicableStudy completedNCT03059953
What this trial is testing

Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)

Who this might be right for
Moderate Plaque Psoriasis
Genesis Pharma S.A. 302
Testing effectiveness (Phase 2)Study completedNCT03706209
What this trial is testing

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
MetrioPharm AG 155
Early research (Phase 1)Study completedNCT03469336
What this trial is testing

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 18
Testing effectiveness (Phase 2)Study completedNCT06061471
What this trial is testing

To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
PsoriasisSkin Diseases
Akeso 454
Not applicableUnknownNCT03952676
What this trial is testing

Moving Cupping for Plaque Psoriasis: a Randomized Controlled Trial

Who this might be right for
Plaque Psoriasis
Shanghai Yueyang Integrated Medicine Hospital 122
Testing effectiveness (Phase 2)UnknownNCT02112097
What this trial is testing

ASIS for Enbrel in Plaque Psoriasis

Who this might be right for
Plaque Psoriasis.
ASIS Corporation 60
Early research (Phase 1)Study completedNCT01937260
What this trial is testing

Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 31
Not applicableEnded earlyNCT02153840
What this trial is testing

Clinical Trial of PSORI-CM01（YXBCM01） Granule to Treat Stable Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Guangdong Provincial Hospital of Traditional Chinese Medicine 35
Testing effectiveness (Phase 2)Study completedNCT05283135
What this trial is testing

High Dose Risankizumab for Psoriasis

Who this might be right for
Psoriasis
Oregon Medical Research Center 20
Not applicableStudy completedNCT01707368
What this trial is testing

Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation

Who this might be right for
Psoriasis VulgarisPlaque Psoriasis
LEO Pharma 561
Testing effectiveness (Phase 2)Study completedNCT01837420
What this trial is testing

Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis

Who this might be right for
Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 194
Large-scale testing (Phase 3)Study completedNCT03255382
What this trial is testing

Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy

Who this might be right for
Psoriasis
AbbVie 120
Large-scale testing (Phase 3)Ended earlyNCT03556202
What this trial is testing

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,936
Large-scale testing (Phase 3)Study completedNCT02742441
What this trial is testing

A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310)

Who this might be right for
Plaque Psoriasis
Therapeutics, Inc. 409
Testing effectiveness (Phase 2)Study completedNCT00687362
What this trial is testing

Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 22
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation